Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Want to see SLNO full AI Analyst Report?
Soleno Therapeutics (SLNO) Ownership Overview
2.00% Insiders
36.16% Mutual Funds
3.16% Other Institutional Investors
12.93% ETFs
45.76% Public Companies and
Individual Investors
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 52.24% of the company’s stock is owned by Institutional Investors, 2.00% is owned by Insiders, and 45.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $200315 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $228923 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $231500 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $51475321 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $266966 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $5974691 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,538,483 | Institution | 4.87% | 134,412,675 | |
| 2,417,215 | Institution | 4.64% | 127,991,534 | |
| 2,155,994 | Institution | 4.14% | 114,159,882 | |
| 2,096,695 | Institution | 4.02% | 111,020,000 | |
| 1,956,056 | Institution | 3.75% | 103,573,165 | |
| 1,946,130 | Institution | 3.73% | 103,047,584 | |
| 1,820,215 | Institution | 3.49% | 96,380,384 | |
| 1,752,552 | Institution | 3.36% | 92,797,628 | |
| 1,320,235 | Institution | 2.53% | 69,906,443 | |
| 1,111,778 | Institution | 2.13% | 58,868,645 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,417,215 | Institution | 4.64% | 127,991,534 | |
| 2,155,994 | Institution | 4.14% | 114,159,882 | |
| 2,096,695 | Institution | 4.02% | 111,020,000 | |
| 1,956,056 | Institution | 3.75% | 103,573,165 | |
| 1,946,130 | Institution | 3.73% | 103,047,584 | |
| 1,320,235 | Institution | 2.53% | 69,906,443 | |
| 714,830 | Institution | 1.37% | 37,850,249 | |
| 492,935 | Institution | 0.95% | 26,100,908 | |
| 487,300 | Institution | 0.93% | 25,802,535 | |
| 459,799 | Institution | 0.88% | 24,346,357 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,656,792 | Institution | 3.18% | 87,727,136 | |
| 1,558,341 | Institution | 2.99% | 52,173,257 | |
| 1,185,904 | Institution | 2.28% | 62,793,617 | |
| 545,296 | Institution | 1.05% | 18,256,510 | |
| 415,019 | Institution | 0.80% | 21,975,256 | |
| 248,060 | Institution | 0.48% | 8,305,049 | |
| 237,649 | Institution | 0.46% | 12,583,515 | |
| 136,693 | Institution | 0.26% | 4,576,482 | |
| 64,597 | Institution | 0.12% | 3,420,411 | |
| 45,925 | Institution | 0.09% | 1,537,569 |
FAQ
Who Owns Soleno Therapeutics Inc (SLNO)?
According to the latest TipRanks data, approximately 3.16% of the company's stock is held by institutional investors, 2.00% is held by insiders, and 45.76% is held by retail investors.
What percentage of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.16% of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors.
What percentage of Soleno Therapeutics Inc (SLNO) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.76% of Soleno Therapeutics Inc (SLNO) stock is held by retail investors.
Who owns the most shares of Soleno Therapeutics Inc (SLNO)?
Vanguard owns the most shares of Soleno Therapeutics Inc (SLNO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.